Abstract:TDP-43 proteinopathy, initially disclosed in amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD), coexists with tauopathy in a variety of neurodegenerative disorders, termed multiple etiology dementias (MEDs), including Alzheimer's Disease (AD). While such co-pathology of TDP-43 is strongly associated with worsened neurodegeneration and steeper cognitive decline, the pathogenic mechanism underlying the exacerbated neuron loss remains elusive. The loss of TDP-43 splicing repression that occurs in presymptomatic ALS-FTD individuals suggests that such early loss could facilitate the pathological conversion of tau to accelerate neuron loss. Here, we report that the loss of TDP-43 repression of cryptic exons in forebrain neurons (CaMKII-CreER;Tardbp f/f mice) is necessary to exacerbate tauopathy-dependent brain atrophy by sensitizing vulnerable neurons to caspase 3-dependent cleavage of endogenous tau to promote tauopathy. Corroborating this finding within the human context, we demonstrate that loss of TDP-43 function in iPSC-derived cortical neurons promotes early cryptic exon inclusion and subsequent caspase 3-mediated endoproteolysis of tau. Using a genetic approach to seed tauopathy in CaMKII-CreER;Tardbp f/f mice by expressing a four-repeat microtubule binding domain of human tau, we show that the amount of tau seed positively correlates with levels of caspase 3-cleaved tau. Importantly, we found that the vulnerability of hippocampal neurons to TDP-43 depletion is dependent on the amount of caspase 3-cleaved tau: from most vulnerable neurons in the CA2/3, followed by those in the dentate gyrus, to the least in CA1. Taken together, our findings strongly support the view that TDP-43 loss-of-function exacerbates tauopathy-dependent brain atrophy by increasing the sensitivity of vulnerable neurons to caspase 3-mediated endoproteolysis of tau, resulting in a greater degree of neurodegeneration in human disorders with co-pathologies of tau and TDP-43. Our work thus discloses novel mechanistic insights and therapeutic targets for human tauopathies harboring co-pathology of TDP-43 and provides a new MED model for testing therapeutic strategies.

Tauopathy-associated PERK alleles are functional hypomorphs that increase neuronal vulnerability to ER stress

Ethnic Variation and Structure‐Function Analysis of Tauopathy‐Associated PERK Alleles

Ethnic variation and structure-function analysis of tauopathy-associated alleles

PERK activation mitigates tau pathology in vitro and in vivo

Defects in the autophagy lysosomal pathway in a cell model of disease‐associated tau

Genetic knock-in of EIF2AK3 variants reveals differences in PERK activity in mouse liver and pancreas under endoplasmic reticulum stress

Depletion of TDP-43 exacerbates tauopathy-dependent brain atrophy by sensitizing vulnerable neurons to caspase 3-mediated endoproteolysis of tau in a mouse model of Multiple Etiology Dementia

Dual leucine zipper kinase-dependent PERK activation contributes to neuronal degeneration following insult

Expression of the Hyperphosphorylated Tau Attenuates ER Stress-Induced Apoptosis with Upregulation of Unfolded Protein Response

PERK activation by SB202190 ameliorates amyloidogenesis via the TFEB-induced autophagy-lysosomal pathway

Phenotypic Discovery of Neuroprotective Agents by Regulation of Tau Proteostasis via Stress‐Responsive Activation of PERK Signaling

The PERKs of mitochondria protection during stress: insights for PERK modulation in neurodegenerative and metabolic diseases

P301S‐hTau Acetylates KEAP1 to Trigger Synaptic Toxicity Via Inhibiting NRF2/ARE Pathway: A Novel Mechanism Underlying Htau‐induced Synaptic Toxicities

The disease-causing tau V337M mutation induces tau hypophosphorylation and perturbs axon morphology pathways

Pathogenic Tau-Induced Pirna Depletion Promotes Neuronal Death Through Transposable Element Dysregulation in Neurodegenerative Tauopathies

PERK Pathway and Neurodegenerative Disease: To Inhibit or to Activate?

Repression of the eIF2α kinase PERK alleviates mGluR-LTD impairments in a mouse model of Alzheimer's disease.

Tau phosphorylation suppresses oxidative stress-induced mitophagy via FKBP8 receptor modulation

Therapeutic Potential of Targeting the PERK Signaling Pathway in Ischemic Stroke

Person‐specific differences in ubiquitin‐proteasome mediated proteostasis in human neurons

The eIF2α kinase PERK limits the expression of hippocampal metabotropic glutamate receptor-dependent long-term depression.